Synapse - Ellin Berman

Results (19)

Leukemias and myelodysplastic syndromes

Book Section

Watts, J. M.; Klimek, V. M.; Tallman, M. S.; Douer, D.; Olson, A. L.; Berman, E.; Intlekofer, A. M.; Zelenetz, A. D.
In Drilon, A. E.; Postow, M. A.; Krug, L. M. (Eds.) Pocket Oncology (2014)

Fulltext@MSK | Save

Chronic myeloid leukemia after adjuvant treatment for breast cancer: Is it therapy related?

Meeting Abstract

Kishtagari, A.; Bowman, I. A.; Tallman, M. S.; Douer, D.; Berman, E.; Maslak, P. G.; Brentjens, R. J.; Stein, E. M.
Blood (2013)

Fulltext@MSK | Save

Safety and efficacy of dose escalated liposomal amphotericin B in adult leukemia patients with refractory invasive fungal infections: A single institution report

Meeting Abstract

Mathew, S.; Harnicar, S.; Halton, E.; Berman, E.; Brentjens, R. J.; Heaney, M. L.; Jurcic, J. G.; Lamanna, N.; Maslak, P. G.; Rosenblat, T. L.; more...
Journal of Clinical Oncology (2012)

Fulltext@MSK | Save

Micafungin versus posaconazole anti-fungal prophylaxis in adult patients with acute leukemia undergoing induction chemotherapy

Meeting Abstract

Halton, E.; Chung, D.; Xiao, K.; Quintanilla, H.; Baldwin, C.; Baird, P.; Berman, E.; Brentjens, R. J.; Heaney, M.; Jurcic, J. G.; more...
Blood (2012)

Fulltext@MSK | Save

Elevated mitochondrial membrane potential in CLL cells is associated with a more aggressive natural history

Meeting Abstract

Gardner, J. R.; Knapp, K.; Frattini, M. G.; Lamanna, N.; Brentjens, R.; Jurcic, J. G.; Maslak, P. G.; Berman, E.; Weiss, M.; Scheinberg, D. A.; more...
Blood (2011)

Fulltext@MSK | Save

Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia

Journal Article

Maslak, P. G.; Dao, T.; Krug, L. M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Zhang, R.; Wolchok, J. D.; Yuan, J.; Pinilla-Ibarz, J.; more...
Blood (2010)

Fulltext@MSK | Save

A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease

Journal Article

Maslak, P. G.; Dao, T.; Gomez, M.; Chanel, S.; Packin, J.; Korontsvit, T.; Zakhaleva, V.; Pinilla-Ibarz, J.; Berman, E.; Scheinberg, D. A.
Leukemia (2008)

Fulltext@MSK | Save

Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease

Meeting Abstract

Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
Journal of Clinical Oncology (2006)

Fulltext@MSK | Save

Induction with combined modality therapy followed by immunomodulated post remission therapy for newly diagnosed acute myeloid leukemia (AML)

Meeting Abstract

Gupta, S.; Weiss, M. A.; Jurcic, J. G.; Chanel, S.; Wilson, B. A.; Biederman, E.; Berman, E.; Scheinberg, D. A.; Maslak, P. G.
Blood (2005)

Fulltext@MSK | Save

Phase I study of a single high dose of liposomal daunorubicin combined with high dose cytarabine for adult patients with relapsed/refractory acute myelogenous leukemia (AML)

Meeting Abstract

Maslak, P.; Weiss, M.; Jurcic, J.; Cathcart, K.; Heaney, M.; Berman, E.; Soignet, S.; Scheinberg, D.; Ward, S.
Blood (2000)

Fulltext@MSK | Save